Thus, determining the mechanisms underlying the oncogenic function of EWS/FLI is critical to understanding Ewing sarcoma tumorigenesis, identifying new therapeutic approaches, and may also shed light on the oncogenic mechanisms of other “ETS-associated” tumors. This evidence concerns the gene FLII and Ewing sarcoma.